CVE-2015-3956

CRITICAL Year: 2015
CVSS v3 Score
9.8
Critical
CVSS v2 Score
10.0
Critical

Vulnerability Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

CVSS:9.8(Critical)

python-keystoneclient version 0.2.3 to 0.2.5 has middleware memcache signing bypass

CVSS:9.8(Critical)

Insufficient type checks were employed prior to casting input data in SimpleXMLElement_exportNode and simplexml_import_dom. This issue affects HHVM versions prior to 3.9.5, all versions between 3.10.0...

CVSS:9.8(Critical)

GIGABYTE BRIX UEFI firmware does not cryptographically validate images prior to updating the system firmware. Additionally, the firmware updates are served over HTTP. An attacker can make arbitrary mo...

CVSS:9.8(Critical)

JFrog Artifactory Pro 6.5.9 has Incorrect Access Control.

CVSS:9.8(Critical)

FreeRADIUS before 3.0.19 mishandles the "each participant verifies that the received scalar is within a range, and that the received group element is a valid point on the curve being used" protection ...

CVSS:9.8(Critical)

Matrix Synapse before 1.5.0 mishandles signature checking on some federation APIs. Events sent over /send_join, /send_leave, and /invite may not be correctly signed, or may not come from the expected ...